Table of Contents
Did you know you can contribute to advancements in scientific and nutraceutical research and be compensated for doing so? Atlantia Clinical Trials is a Chicago-based clinical research organization (CRO) that allows you to do just that. Throughout the remainder of this article, you will learn more about Atlantia’s mission, ongoing clinical trials, and why they’re considered the gold standard of paid research studies in Chicago.
You may be wondering why you’re finding this article on a health and fitness website. The answer is simple – Atlantia is a local business that we’re happy to endorse because our core values align. If you live near the Chicagoland area, you will definitely want to learn more about this company.
The majority of Atlantia’s trials are nutrition-based, although they occasionally dabble in the bio-therapeutics and beauty space. It all started in 2011 when a team of researchers decided there was limitless potential in establishing a nutraceutical based clinical trials company in Cork, Ireland. Once the idea was born, the company spun out of University College Cork (UCC) and immediately honed in on their unique business model.
Despite being an independent research organization, Atlantia maintains close ties with academic institutions to improve and maintain its vast network of researchers. This unique approach proved to be a big success as Atlantia grew from 8 employees in June of 2013, to over 75 employees in October of 2021. Atlantia now proudly operates two ICH-GHP compliant clinic sites in Cork, Ireland and Chicago, Illinois. The Chicago site will be the primary focus for the remainder of this reading.
IBS Clinical Trial
Atlantia’s Chicago clinic is currently enrolling participants for a research study concerning IBS. Irritable bowel syndrome, or IBS, is a gastrointestinal condition that normally results in consistent constipation, diarrhea, or abdominal discomfort. Roughly 500 participants will be recruited for this study, thus making it one of the largest clinical trials for IBS in Chicago.
In order to be eligible for this study, you must have a confirmed IBS diagnosis from a medical professional. Please note that there are several different subtypes of IBS, but all of them are acceptable to participate in this study. For example, you could have IBS-C, IBS-D, or IBS-mixed and still participate if a diagnosis was previously obtained.
The purpose of this study is to determine the effectiveness of an investigational product on improving IBS symptoms. In this case, the investigational product is a non-digestible carbohydrate mix that is synthesized from lactose to replicate the carbohydrates found in HMOs (Human milk oligosaccharides). The product is not human-derived, however, it replicates the carbohydrates found in breast milk which have been found to alleviate the symptoms of IBS. If you choose to participate in this trial, you will be taking the study product or a placebo once a day for 12 weeks.
You can expect to attend 3 visits at Atlantia’s Chicago office, as well as two phone call check-ins over the course of 15 weeks if you choose to participate. Blood, urine, and stool samples will be collected periodically throughout the study to assess the safety and overall impact of the study product on your health. You will periodically be queried regarding your IBS symptoms and asked to use a mobile application to report certain health information.
Although there are no guaranteed benefits from participating in this trial, you can take pride in knowing that people in the future may benefit from this research. You will also receive regular health checks (anthropometrics, blood results, etc..). Participants will be compensated $500 for their time and effort.
For more information on Atlantia’s IBS research study, and to determine your eligibility, please see below.
Pre-Diabetes Clinical Trial
Atlantia is also currently enrolling for a pre-diabetes clinical trial in Chicago and Cork, Ireland. If you are confirmed to have or think you fit the criteria for pre-diabetes, this study may be worth looking into. Men aged 21-69 and women aged 45-69 (post-menopausal) can participate in this study. You must either have high blood sugar levels or be type II diabetic and unmedicated for a period of over 3 months to participate.
Please note that the Chicago clinic will be nearing the end of the recruitment period for this study soon. If you’re in the Chicagoland area and have pre-diabetes, please see the pre-screening questionnaire on Atlantia’s website. Potential participants who are unsure of their blood sugar levels can still go through the screening procedure to determine eligibility.
Atlantia expects many upcoming trials in its pipeline at both the Chicago and Cork sites. Some of the trials will specifically recruit healthy participants, while others will focus specifically on diseased populations. The best way to stay informed about upcoming trials is to sign up for their e-mail list or regularly check their website for updates.
Atlantia Clinical Trials is a relatively new CRO in Chicago – and one that is expected to grow exponentially. As of right now, they are currently enrolling for an IBS research study and pre-diabetes study, but there will be trials servicing healthy volunteers in the near future. There is a study on CBD supplements expected to start in late March of this year too.
Although Atlantia’s staff has expertise in a multitude of fields, the company can primarily be described as a nutraceutical research center. They have conducted a plethora of research concerning the gut microbiome and human nutrition.
If you’re interested in contributing to research or simply participating in paid clinical trials in Chicago or Cork, Ireland, I strongly suggest checking out Atlantia Clinical Trials.
Located off of Chicago’s magnificent mile at:
142. E. Ontario Suite 1200
or in Ireland at:
Floor 1, Heron House,
Ireland. T23 R50R